• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS/RESPIRONICS, INC. DREAM STATION CPAP MACHINE; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS/RESPIRONICS, INC. DREAM STATION CPAP MACHINE; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Device Problem Unexpected Therapeutic Results (1631)
Patient Problems Dysphagia/ Odynophagia (1815); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 09/01/2021
Event Type  Injury  
Event Description
I have had barrett's esophagus for approximately 6 years, and recently i had another scraping of my esophagus.I was unable to eat, drink, and was having trouble swallowing, and my voice changed where i could not be understood with what i was trying to say, so i went to the er and they did the scraping where not only polyps were attached to my esophagus.They were also attached to my adenoids and came back malignant on (b)(6) 2022, spent 4 days in the hospital.I used my cpap on a regular basis.I'm thinking the problem might have been caused by dreamscapes cpap machine.Philips should be on the bottom.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DREAM STATION CPAP MACHINE
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS/RESPIRONICS, INC.
MDR Report Key15720414
MDR Text Key303077022
Report NumberMW5113057
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 11/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/02/2022
Patient Sequence Number1
Treatment
FISH OIL; AUSTEDO 15 MG TWICE DAILY; BENZTROPINE 1MG TWICE A DAY; CALCIUM; CARVEDILOL 3.12 2X DAILY; DICYCLOMINE 20MG 3X DAILY ; GABAPENTIN 600MG 2 TABS TWICE DAILY; HYDROXOXYCHLOROQUINE 200MG 2X DAILY; INGRREZZA 60MG DAILY; IRON SUPPLEMENT; KLONOPIN2MG 2X DAILY; LATUDE 60MG DAILY; MIDODRINE 2.5 3X DAILY; NIFEDIPINE 10MG 3TIMES DAILY; OMEPRAZOLE 20MG TWICE DAILY; ONE ADAY; PRAVASTATIN 40MG DAILY; PRAZOSIN 1MG 3X DAILY; ROPINIROLE .5 AT BEDTIME; VENLAFAXINE 75MG DAILY; VITAMIN D
Patient Outcome(s) Disability;
Patient Age50 YR
Patient SexFemale
Patient Weight102 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-